Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial
Status:
Completed
Trial end date:
2002-07-30
Target enrollment:
Participant gender:
Summary
To determine whether the use of two antiviral agents in combination will be better than
placebo in the treatment of an inflammatory sidease of the spinal cord caused by HTLV-I